IL6 and Nasal polyposis: There is recent evidence that patients with N-ERD present a heterogeneous set of dysregulated inflammatory cytokines, both type 2, innate lymphoid cells and IL-6 related cytokines which are elevated in the respiratory tract, oncostatin M and IL-6 overproduction are produced locally in nasal polyps and probably cause epithelial barrier disruption.